Our findings support the idea that AR activation in a low androgen environment, a hallmark of CRPC, can be tumor-suppressive in advanced PCa, harking back to the anti-proliferative/pro-differentiation role of AR in normal prostate53. Here, AR is linked to posterior cortical atrophy.